Recurrence of hepatitis B after single lung transplantation

Journal of Heart and Lung Transplantation

Volumn 18, Issue 12, 1999, Pages 1246-1250

  Stamenkovic, Steven Aleksandar ^a   Alphonso, Nelson ^a   Rice, Philip ^a   Madden, Brendan Patrick ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CASE REPORT; FEMALE; GRAFT REJECTION; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AZATHIOPRINE; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B, CHRONIC; HUMANS; IMMUNOSUPPRESSION; LUNG TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREDNISOLONE; RECURRENCE; RESPIRATORY INSUFFICIENCY;

EID: 0032715633     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(99)00097-2     Document Type: Article

References (16)

1. Nagington J, Cossart Y, Cohen BJ. Reactivation of Hepatitis B after transplantation operation. Lancet 1977;March 12th 558-60.
2. Sagnelli E, Maio G, Felaco F et al. Serum levels of Hepatitis B surface and core antigen during immunosuppression treatment of HBsAg-positive chronic active hepatitis. Lancet 1980:August 23rd: 395-7.
3. Angus P. Review Hepatitis B and liver transplantation . J Gastr Hepatol. 12:1997;217-223.
4. Fung J.J., Eghtesad B., Todo S., et al. Hepatitis B virus (HBV) re-infection following liver transplantation theory and practice . Clin Transpl. 9:1995;262-268.
5. Bird G., Smith H., Portmann B., Alexander G., Williams R. Acute liver decompensation on withdrawal of chemotherapy and immunosuppressive therapy in hepatitis B carriers. Quarterly Journal of Medicine. 270:1989;895-902.
6. Brechot C., Kreunsdorf D., Paterlini P., et al. Hepatitis B Virus DNA in HBsAg-negative patients Molecular characterization and clinical implications . J Hepatol. 13:1991;S49.
7. Samuel D., Bismuth A., Matthew D., et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet. 337:1991;813-815.
8. Brunetto M., Cerenzia M., Oliveri F., Piantino P., Randone A., Calvo P., Manzini P., Rocca G., Galli C., Borino F. Monitoring the response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol. 19:1993;431-436.
9. Smith H., Lau J., Davies S., Daniels H., Alexander G., Williams R. Significance of serum IgM anti-HBc in chronic hepatitis B virus infection. J Med Virol. 36:1992;16-20.
10. Chossegros P., Ponteil-Noble C., Samuel D., et al. Ganciclovir is an effective anti-viral agent for post-transplantation chronic HBV infections, maintenance therapy may be required in some cases. [abstract] Gastr. 104:1993;A888.
11. Perrillo R.P. Treatment of posttransplantation Hepatitis B. Liver Transplantation and Surgery. 3:(suppl 1):1997;S8-S12.
12. Gish R.G., Keefe E.B., Fang J.W.S., et al. Ganciclovir treatment of recurrent Hepatitis B virus (HBV) infection in orthotopic liver transplant recipients. [abstract] Gastr. 104:1993;A908.
13. Nelson S.R., Snowden S.A., Sutherland S., et al. Outcome of renal transplantation in hepatitis BsAg-positive patients. Nephro Dial Transplant. 9:1994;1320-1323.
14. Anand B.S., Yoffe B., Young J.B. Ganciclovir treatment of active Hepatitis B virus infection in a heart transplant patient. J Clin Gastr. 22:1996;144-146.
15. Wright H.I., Gavalier J.S., Van Thiel D.H. Preliminary experience with α-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transpl. 53:1992;121.
16. McMahon G., Erlich P.H., Moustafa Z.A., et al. Genetic alterations in the gene encoding the major HBsAg DNA and the immunologic analysis of recurrent HBsAg derived from monoclonal antibody treated liver transplant patients . Hepatol. 15:1992;757.